Search Results - "Luo, Chengjuan"
-
1
Successful Treatment of Pediatric Refractory Burkitt Lymphoma PTLD after Liver Transplantation using Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy
Published in Cell transplantation (2021)“…In the immunocompromised setting, recipients of solid-organ or hematopoietic stem-cell transplants carry an increased risk of post-transplant…”
Get full text
Journal Article -
2
TCRαβ-depleted hematopoietic stem cell transplant and third-party CD45RA+ depleted adoptive cell therapy for treatment of post-transplant parvovirus B19 aplastic crisis
Published in International journal of infectious diseases (01-07-2024)“…•Persistent B19 infection can lead to aplastic crisis and graft rejection.•TCRαβ-depleted HSCT can treat secondary graft rejection.•The third-party CD45RA+…”
Get full text
Journal Article -
3
PTPN11 mutation with additional somatic alteration indicates unfavorable outcome in juvenile myelomonocytic leukemia: a retrospective clinical study from a single center
Published in European journal of pediatrics (01-03-2020)“…Juvenile myelomonocytic leukemia (JMML) is a heterogeneous childhood leukemia. The management of patients with JMML requires accurate assessment of genetic and…”
Get full text
Journal Article -
4
Case Report: Unedited allogeneic chimeric antigen receptor T cell bridging to conditioning-free hematopoietic stem cell transplantation for a child with refractory Burkitt lymphoma
Published in Frontiers in immunology (06-09-2023)“…Purpose Burkitt lymphoma (BL) is the most common tumor of non-Hodgkin’s lymphoma (NHL) in children, accounting for about 40% of cases. Although different…”
Get full text
Journal Article -
5
Safety and efficacy of co-administration of CD19 and CD22 CAR-T cells in children with B-ALL relapse after CD19 CAR-T therapy
Published in Journal of translational medicine (22-03-2023)“…CD19-targeted chimeric antigen receptor T-cell (CAR-T) therapy has shown remarkable efficacy in treating relapsed or refractory pediatric B-lineage acute…”
Get full text
Journal Article -
6
Outcomes of Anti-CD19 CAR-T Treatment of Pediatric B-ALL with Bone Marrow and Extramedullary Relapse
Published in Cancer research and treatment (01-07-2022)“…Anti-CD19 chimeric antigen receptor T-cell immunotherapy (19CAR-T) has achieved impressive clinical results in adult and pediatric relapsed/refractory (r/r)…”
Get full text
Journal Article -
7
Toxoplasma gondii infection in children after allogeneic hematopoietic stem cell transplantation: A case report and literature review
Published in Pediatric investigation (01-09-2021)“…ABSTRACT Introduction Toxoplasmosis is a life‐threatening complication after hematopoietic stem cell transplantation (HSCT). However, for several reasons,…”
Get full text
Journal Article -
8
One-Stop No-Edited Allogenic CAR-T Therapy Bridging HSCT to Treat Children with Relapse and Refractory Acute Lymphoblastic Leukemia: A Prospective Clinical Study from a Single Center
Published in Blood (02-11-2023)“…Object: Chimeric Antigen Receptor T-Cell (CAR-T) therapy has been developed to be the most effective treatment for relapse and refractory(R/R) B-cell acute…”
Get full text
Journal Article -
9
Lianhua Qingwen protects LPS-induced acute lung injury by promoting M2 macrophage infiltration
Published in Journal of ethnopharmacology (10-02-2024)“…ETHNOPHARMACOLOGICAL RELEVANCETraditional Chinese medicine Lianhua Qingwen (LHQW) was used to treat regular seasonal influenza. In recent years, LHQW exerts…”
Get full text
Journal Article -
10
Further delineation of bone marrow failure syndrome caused by novel compound heterozygous variants of MYSM1
Published in Gene (05-10-2020)“…•Identification a novel compound heterozygous variants of MYSM1 in a Chinese patient with bone marrow failure syndrome.•The first report of a pathogenic…”
Get full text
Journal Article -
11
Droplet digital PCR: An effective method for monitoring and prognostic evaluation of minimal residual disease in JMML
Published in British journal of haematology (01-06-2024)“…Juvenile myelomonocytic leukaemia (JMML) is a rare myeloproliferative neoplasm requiring haematopoietic stem cell transplantation (HSCT) for potential cure…”
Get full text
Journal Article -
12
Metagenomic next-generation sequencing in detecting pathogens in pediatric oncology patients with suspected bloodstream infections
Published in Pediatric research (01-02-2024)“…Background Studies on mNGS application in pediatric oncology patients, who are at high risk of infection, are quite limited. Methods From March 2020 to June…”
Get full text
Journal Article -
13
Coadministration of CD19- and CD22-Directed Chimeric Antigen Receptor T-Cell Therapy in Childhood B-Cell Acute Lymphoblastic Leukemia: A Single-Arm, Multicenter, Phase II Trial
Published in Journal of clinical oncology (20-03-2023)“…We determined the safety and efficacy of coadministration of CD19- and CD22-chimeric antigen receptor (CAR) T cells in patients with refractory disease or…”
Get full text
Journal Article -
14
Improved Grfs Observed in a Multicenter Prospective Study of Tcrαβ- and CD45RA-Depleted Haploidentical Transplant in Children with Acute Leukemia
Published in Blood (15-11-2022)Get full text
Journal Article -
15
The efficacy and safety of a homoharringtonine-based protocol for children with acute myeloid leukemia: A retrospective study in China
Published in Pediatric hematology and oncology (01-03-2021)“…The standard chemotherapy for acute myeloid leukemia (AML) is usually composed of anthracyclines and cytarabine. We previously reported that homoharringtonine…”
Get full text
Journal Article -
16
The impact of donor full‐length KIR2DS4 in the development of acute and chronic GVHD after unrelated allogeneic HSCT
Published in Pediatric transplantation (01-09-2020)“…Background Killer Ig‐like receptor 2DS4 (KIR2DS4) is the most prevalent activating killer Ig‐like receptor gene. It is divergent and encodes either full‐length…”
Get full text
Journal Article -
17
Disease-specific hematopoietic stem cell transplantation in children with inherited bone marrow failure syndromes
Published in Annals of hematology (01-08-2017)“…Hematopoietic stem cell transplantation (HSCT) using an optimized conditioning regimen is essential for the long-term survival of patients with inherited bone…”
Get full text
Journal Article -
18
-
19
Fludarabine- and low-dose cyclophosphamide-based conditioning regimens provided favorable survival and engraftment for unmanipulated hematopoietic cell transplantation from unrelated donors and matched siblings in patients with Fanconi anemia: results from the CBMTR
Published in Bone marrow transplantation (Basingstoke) (01-01-2023)Get full text
Journal Article -
20
Prognostic factors and outcome of patients undergoing hematopoietic stem cell transplantation who are admitted to pediatric intensive care unit
Published in BMC pediatrics (20-08-2016)“…There are many studies about the prognosis and possible predictive factors of mortality for pediatric allogeneic hematopoietic stem cell transplantation (HSCT)…”
Get full text
Journal Article